×
For best experience we recommend to activate Javascript in your browser.
KAL1 antibody (AA 548-657)
This anti-KAL1 antibody is a Mouse Polyclonal antibody detecting KAL1 in WB and ELISA. Suitable for Human. This Primary Antibody has been cited in 1 publication.
Quick Overview for KAL1 antibody (AA 548-657) (ABIN561573)
Target
See all KAL1 Antibodies
KAL1
(Kallmann Syndrome 1 Sequence (KAL1))
Reactivity
All reactivities for KAL1 antibodies
Human
Host
All hosts for KAL1 antibodies
Mouse
Clonality
All clonalities for KAL1 antibodies
Polyclonal
Conjugate
All conjugates for KAL1 antibodies
This KAL1 antibody is un-conjugated
Application
All applications for KAL1 antibodies
Western Blotting (WB), ELISA
Product Details anti-KAL1 Antibody
(hide)
Binding Specificity
All epitopes for KAL1 antibodies
AA 548-657
Purpose
Mouse polyclonal antibody raised against a partial recombinant KAL1.
Sequence
LAKPENLSAS FIVQDVNITG HFSWKMAKAN LYQPMTGFQV TWAEVTTESR QNSLPNSIIS QSQILPSDHY VLTVPNLRPS TLYRLEVQVL TPGGEGPATI KTFRTPELPP
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
KAL1 (NP_000207, 548 a.a. ~ 657 a.a) partial recombinant protein with GST tag.
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
50 % glycerol
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
References for anti-KAL1 antibody (ABIN561573)
(hide)
Hu, Yu, Shaw, Pask, Renfree : "Kallmann syndrome 1 gene is expressed in the marsupial gonad. " in: Biology of reproduction , Vol. 84 , Issue 3 , pp. 595-603 , (2011 ) (PubMed ).
Target Details for KAL1
(hide)
Target
KAL1
(Kallmann Syndrome 1 Sequence (KAL1))
Alternative Name
KAL1
Background
Full Gene Name: Kallmann syndrome 1 sequence Synonyms: ADMLX,HHA,KAL,KALIG-1,KMS
Gene ID
3730
NCBI Accession
NM_000216
Recently viewed
(hide)
Chat with us , powered by LiveChat